PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.447
https://www.valueinhealthjournal.com/article/S1098-3015(11)02009-2/fulltext
Title :
PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02009-2&doi=10.1016/j.jval.2011.08.447
First page :
A313
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
416